Glaxosmithkline Plc Return On Asset Over Time

GSK -  USA Stock  

USD 40.10  0.60  1.52%

With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Please check Glaxosmithkline Plc Performance and Glaxosmithkline Plc Correlation.

Search Competitors Fundamentals Over Time Against Return On Asset 

 
Refresh
The current Average Assets is estimated to decrease to about 74.6 B. Tangible Asset Value is estimated to decrease to about 39.8 B.
The market value of Glaxosmithkline Plc ADR is measured differently than its book value, which is the value of Glaxosmithkline that is recorded on the company's balance sheet. Investors also form their own opinion of Glaxosmithkline Plc's value that differs from its market value or its book value, called intrinsic value, which is Glaxosmithkline Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Glaxosmithkline Plc's market value can be influenced by many factors that don't directly affect Glaxosmithkline Plc ADR underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Glaxosmithkline Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine Glaxosmithkline Plc value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Glaxosmithkline Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Specify up to 10 symbols:


Cross Equities Return on Average Assets Analysis

Compare Glaxosmithkline Plc ADR and related stocks such as Horizon Therapeutics Return On Asset Over Time
Select Fundamental

201020112012201320142015201620172018201920202021
HZNP
(0.319)(0.717)(0.485)(0.806)(0.368)0.015(0.047)(0.083)(0.01)0.1450.0750.0809

Glaxosmithkline Plc ADR and related stocks such as Horizon Therapeutics Return on Average Assets description

Return on assets measures how profitable a company is Net Income Common Stock relative to its total assets [AssetsAvg].

My Equities

My Current Equities and Potential Positions

GSK - USA Stock
Glaxosmithkline Plc ADR
GSK
Glaxosmithkline Plc Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
RegionEurope
ExchangeNew York Stock Exchange
$40.1
Please check Glaxosmithkline Plc Performance and Glaxosmithkline Plc Correlation. Note that the Glaxosmithkline Plc ADR information on this page should be used as a complementary analysis to other Glaxosmithkline Plc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Complementary Tools for Glaxosmithkline Stock analysis

When running Glaxosmithkline Plc ADR price analysis, check to measure Glaxosmithkline Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Glaxosmithkline Plc is operating at the current time. Most of Glaxosmithkline Plc's value examination focuses on studying past and present price action to predict the probability of Glaxosmithkline Plc's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Glaxosmithkline Plc's price. Additionally, you may evaluate how the addition of Glaxosmithkline Plc to your portfolios can decrease your overall portfolio volatility.
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
The market value of Glaxosmithkline Plc ADR is measured differently than its book value, which is the value of Glaxosmithkline that is recorded on the company's balance sheet. Investors also form their own opinion of Glaxosmithkline Plc's value that differs from its market value or its book value, called intrinsic value, which is Glaxosmithkline Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Glaxosmithkline Plc's market value can be influenced by many factors that don't directly affect Glaxosmithkline Plc ADR underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Glaxosmithkline Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine Glaxosmithkline Plc value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Glaxosmithkline Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.